AVS Rakes in $20M to Advance Plaque-shattering Arterial Disease Treatment
Boston-based medical device company AVS recently raised $20 million in Series B funding to bring its arterial disease treatment closer to FDA clearance. The system that AVS is developing uses pressure waves to shatter calcium that has built up in arteries.